Format

Send to

Choose Destination
Anticancer Res. 2020 Feb;40(2):915-921. doi: 10.21873/anticanres.14024.

Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy.

Author information

1
Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan takashi.yokokawa@jfcr.or.jp.
2
Division of Applied Pharmaceutical Education and Research Hoshi University, Tokyo, Japan.
3
Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
4
Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
5
Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Abstract

BACKGROUND/AIM:

This study aimed was to clarify the impact of pegfilgrastim (PEG) 3.6 mg primary prophylaxis of febrile neutropenia (FN) on the average relative dose intensity (ARDI) of neoadjuvant/adjuvant FEC-100 for breast cancer.

MATERIALS AND METHODS:

This retrospective, single-centre cohort study including 296 patients who received FEC-100 compared PEG and non-PEG groups. The PEG group received PEG 3.6 mg as a single subcutaneous injection in each study cycle. The primary endpoint was the ARDI of FEC-100. The secondary endpoints were patient percentage of ARDI≥85%, factors associated with ARDI≥85%, and reasons for reduced ARDI.

RESULTS:

The PEG group showed significantly higher mean ARDI (95.6% versus 90.7%, p<0.001) and patient percentage of ARDI≥85% (93.0% versus 79.9%, p=0.001). PEG was significantly associated with ARDI≥85% (p=0.009). Neutropenia and FN, the main reasons for reduced ARDI, were significantly lower in the PEG group (p<0.05).

CONCLUSION:

Primary PEG 3.6 mg prophylaxis increased the ARDI of FEC-100.

KEYWORDS:

FEC-100; Pegfilgrastim; breast cancer; febrile neutropenia; relative dose intensity

PMID:
32014935
DOI:
10.21873/anticanres.14024

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center